MOBX.NASDAQMobix Labs, INC

SCHEDULE: Armistice Capital Discloses 8.4% Stake in MOBIX LABS

Sentiment:

Beneficial Ownership Report


Armistice Capital, LLC and Steven Boyd have reported a beneficial ownership of 8.4% in MOBIX LABS, totaling 4,596,804 shares of common stock.

Summary

  • Armistice Capital, LLC and Steven Boyd (collectively, the "Reporting Persons") have filed a Schedule 13G with the SEC regarding their ownership in MOBIX LABS.
  • The Reporting Persons beneficially own 4,596,804 shares of MOBIX LABS' common stock, par value $.001 per share.
  • This ownership stake represents 8.40% of the total class of securities outstanding.
  • The percentage is calculated based on 54,734,338 shares of MOBIX LABS common stock outstanding as of July 31, 2025, as reported in the Issuer's Form 10-Q filed on August 13, 2025.
  • Armistice Capital, LLC, as the investment manager of Armistice Capital Master Fund Ltd., and Steven Boyd, as the managing member of Armistice Capital, exercise shared voting and dispositive power over these shares.
  • The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of MOBIX LABS.

Sentiment

Score: 5

Explanation: A Schedule 13G is a factual disclosure of beneficial ownership and does not inherently convey positive or negative sentiment regarding the issuer's performance or prospects. It is a neutral regulatory filing.

Positives

  • NA

Negatives

  • NA

Risks

  • NA

Future Outlook

NA

Management Comments

  • Steven Boyd, as Managing Member of Armistice Capital, LLC and individually, certified that the securities were acquired and are held in the ordinary course of business and not for the purpose of or with the effect of changing or influencing the control of MOBIX LABS, nor in connection with any transaction having that purpose or effect, other than activities solely in connection with a nomination under ยงยง 240.14a-11.

Industry Context

NA

Stakeholder Impact

  • Shareholders: The disclosure of a significant institutional stake (8.4%) by Armistice Capital and Steven Boyd may be viewed as a vote of confidence in MOBIX LABS, potentially influencing investor perception, although the filing explicitly states no intent to influence control.

Key Dates

DateDescription
2025-07-31Date of shares outstanding calculation for MOBIX LABS (54,734,338 shares) as reported in Form 10-Q.
2025-08-13Date MOBIX LABS filed its Form 10-Q with the Securities and Exchange Commission.
2025-09-30Date of event which required the filing of this Schedule 13G statement.
2025-11-14Date the Schedule 13G was signed and filed by Armistice Capital, LLC and Steven Boyd.

Recommendation

hold

This filing is a disclosure of a significant ownership stake by an institutional investor. While it indicates a notable position, it does not provide new financial performance data or strategic updates from MOBIX LABS itself. The filing explicitly states the shares were acquired in the ordinary course of business and not for the purpose of changing or influencing control. Therefore, without additional information, a 'hold' recommendation is appropriate as it's a factual disclosure rather than a catalyst for immediate re-evaluation of the company's fundamentals.

Keywords

MOBIX LABS, Armistice Capital, Steven Boyd, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, Equity Stake, SEC Filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.